Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of co-administering seasonal malaria chemoprevention and deworming drugs in Senegalese children
PACTR202204794105273Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of amodiaquine, sulfadoxine + pyrimethamine, albendazole and praziquantel in malaria, Soil-Transmitted Helminthiases (STH) and schistosomiasis (2 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Solicited and unsolicited adverse events and adverse drug reactions. Started Jun 2022; status: completed.
02
Drugs
amodiaquinesulfadoxine + pyrimethaminealbendazolepraziquantel
03
Conditions
malariaSoil-Transmitted Helminthiases (STH)schistosomiasis
Beyond the preview
Go deeper on PACTR202204794105273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202204794105273.